Category: Joint ventures/collaborations
-
Biotech Companies to Discover Ebola, Zika Vaccines
Two biotechnology companies are collaborating to discover new vaccines protecting against Ebola and Zika viruses that present global threats to public health.
-
Genome Editing Builds Viral Disease Resistance in Pigs
Veterinary researchers used Crispr-Cas9, an emerging genome editing technique, to produce pigs with cells resistant to a common viral disease affecting commercial herds.
-
Skin Health Data Collected by App Offered for Research
A smartphone app collecting images and data about moles on the skin of volunteers is now available to researchers for studies of cancer and other disorders.
-
Ford Investing $1B in Artificial Intelligence Start-Up
Ford Motor Company is investing $1 billion in a start-up enterprise that applies artificial intelligence to the operation and management of autonomous vehicles.
-
Company, NC State Partner on Tissue Oxygen Patch
Profusa Inc. and a research center at North Carolina State University are developing a new device to monitor tissue oxygen levels in people with peripheral artery disease.
-
Alliance to Study Brain Tumor Precision Diagnostics
A group of medical centers and companies, mainly in Philadelphia, is beginning a study of genomic profiling to diagnose brain tumors in adults and children.
-
EU Project to Develop More Versatile Heart Pacemakers
An initiative in Europe plans to design a new type of pacemaker device that adapts to a host of signals in the cardiovascular system and regulates multiple heart functions.
-
Grid Computing Harnessed for Childhood Cancer Research
An international consortium is seeking crowdsourced computing power to screen drug candidates for treating a number of cancers affecting children.
-
Novo Nordisk to Open Oxford Diabetes Research Center
The pharmaceutical company Novo Nordisk will build a research center to study type 2 diabetes on the campus of University of Oxford in the U.K.
-
Neuro Device Company to Begin Clinical Trials in Europe
Clinical trials in Europe are set to begin to test a non-invasive device that stimulates nerves and the spinal cord to treat neuromotor disorders.